Accelerating discovery through equity-focused, efficient, and data-driven services
Rubix LS provides a full suite of CRO services that fast-track research from early discovery to clinical trials. Our approach is designed to serve clients seeking a research partner who combines technical expertise with a commitment to inclusivity. Focusing on underserved patient data and deploying advanced research methodologies, we help our clients achieve impactful results that reflect real-world needs and realities.
OUR COMMITMENT: PIONEERING RESEARCH WITH PRECISION & INCLUSIVITY
Rubix LS focuses on designing and executing pre-clinical through Phase II trials for underserved communities. By utilizing pop-up mobile clinical sites, we bring research directly to remote areas, improving access and ensuring inclusive, patient-centered healthcare solutions.
Our services for complex challenges
Pre-clinical research in specialized areas
-
PK/PD Studies: Our preclinical services include in-depth Pharmacokinetics (PK) and Pharmacodynamics (PD) studies, crucial for understanding the absorption, distribution, metabolism, excretion (ADME), and therapeutic effects of potential drug candidates. This essential analysis informs dosing, efficacy, and safety profiles, guiding the progression to clinical trials.
​
-
Focused Study Design: We develop specialized study designs for Infectious Disease, Ultra Rare, Rare Disease, and Chronic Conditions, leveraging our extensive expertise to address the unique challenges of these areas.
Clinical trial management: from patients to progress
-
Ethical and Representative Recruitment: Specializing in patient recruitment for challenging populations, we ensure ethical and effective clinical trials in specialized disease areas.
​
-
Regulatory Adherence: Our team excels in navigating the complex regulatory landscapes specific to Infectious Disease, Ultra Rare, and Rare Disease research.
Bioinformatics and Data Analysis: Unlocking Insights
-
Data-Driven Decisions: Utilizing sophisticated bioinformatics tools, we manage and analyze complex datasets, providing critical insights for your research.
​
-
AI Integration: Our AI capabilities enhance data interpretation, especially in intricate fields like Infectious Disease, Ultra Rare, and Rare Disease, and Chronic Conditions.
Customized Research Services for Your Unique Needs
Our approach is to customize each project to your specific research goals. We cater to a diverse range of clients, from emerging biotech startups to established pharmaceutical companies, offering tailored strategies and dedicated support.
-
Strategic Planning for Specialized Research: Our strategies are crafted to address the unique challenges of Infectious Disease, Ultra Rare, and Rare Disease research.
​
-
Expert Teams for Focused Outcomes: Benefit from our team of seasoned professionals who bring specialized knowledge and experience in these disease areas.
Services
-
Clinical Trial Execution
-
Pre-clinical
-
Phase I
-
Phase II
-
Phase III (Partnered)
-
Phase IV (Partnered)
-
-
Trial Design & Protocol Development
-
Custom Trial Design
-
Protocol Development
-
-
Patient Recruitment & Management​
-
Patient Care & Management​​
-
-
Safety Monitoring & Adverse Event Reporting​
-
Continuous Monitoring and Safety Management​
-
Reach out to a team member today to find out more information.
Partner with Us – Transforming Research, Together
Rubix LS is committed to partnering with organizations that prioritize innovative and inclusive research. Whether you’re looking for a strategic CRO partner or need support with an early-stage discovery program, our catalyst approach ensures that your project achieves timely and impactful results.
IHeadquarters:
60 Island St, Suite 236
Lawrence, MA 01840
Tel: 978-552-3183
© 2023 by Rubix LS.